Characterizing the SASP-Dependent Paracrine Spreading of Senescence Between Human Brain Cell Types.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro laboratory study using cell models without human clinical data.
PubMed 42601837 · doi:10.1111/acel.70673
What was done
The authors profiled cell-type-specific senescence-associated secretory phenotype (SASP) profiles and mapped the directionality of paracrine senescence spreading among major human brain cell types in vitro. They identified specific SASP ligand-receptor pairs involved in this transmission and tested targeted inhibitors against selected factors to evaluate whether paracrine senescence propagation could be blocked.
What was found
Specific SASP ligand-receptor pairs were identified as mediators of paracrine senescence dissemination between human brain cell types. Treatment with selected inhibitors ameliorated aspects of this paracrine spreading in a cell-type-dependent manner. The abstract reports no quantitative values, effect sizes, specific ligand-receptor names, or inhibitor identities.
Why it matters
This study identifies specific SASP-mediated transmission pathways between human brain cell populations. These findings highlight potential molecular targets to prevent the non-cell-autonomous spread of senescence and associated neuroinflammation in aging and neurodegenerative disorders.
Limits
The work is limited to preclinical in vitro models, which do not fully replicate the intact human brain microenvironment or complex neurodegenerative pathology. The abstract provides no sample sizes, specific cell sources, quantitative metrics, effect sizes, or named molecular targets and inhibitors.
Cited by
- supports Senescent cells secrete signaling molecules and factors that cause damage to neighboring cells.